56
Participants
Start Date
August 28, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
April 5, 2027
Loncastuximab Tesirine
Intravenous (IV) Infusion
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Kyungpook National University Chilgok Hospital, Daegu
COMPLETED
The Oncology Institute of Hope & Innovation - Lynwood, Lynwood
RECRUITING
Hospital Sírio-Libanês - Brasília, Brasília
RECRUITING
Hospital Mãe de Deus - Centro Integrado de Oncologia, Porto Alegre
RECRUITING
Hospital Sírio-Libanês - São Paulo, São Paulo
RECRUITING
A Beneficência Portuguesa de São Paulo - Unidade Mirant, São Paulo
RECRUITING
Hospital 9 de Julho, São Paulo
RECRUITING
Albert Einstein Israelite Hospital, São Paulo
RECRUITING
Dong-A University Hospital, Pusan
ACTIVE_NOT_RECRUITING
Korea University Anam Hospital, Seoul
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital, Seoul
RECRUITING
Koo Foundation Sun Yat-Sen Cancer Center, Taipei
Lead Sponsor
ADC Therapeutics S.A.
INDUSTRY